The mRNA-LNP vaccines–the good, the bad and the ugly?

BZ Igyártó, Z Qin - Frontiers in immunology, 2024‏ - frontiersin.org
The mRNA-LNP vaccine has received much attention during the COVID-19 pandemic since
it served as the basis of the most widely used SARS-CoV-2 vaccines in Western countries …

N1-methyl-pseudouridine (m1Ψ): Friend or foe of cancer?

A Rubio-Casillas, D Cowley, M Raszek… - International Journal of …, 2024‏ - Elsevier
Due to the health emergency created by SARS-CoV-2, the virus that causes the COVID-19
disease, the rapid implementation of a new vaccine technology was necessary. mRNA …

Modulation of innate immune response to mRNA vaccination after SARS-CoV-2 infection or sequential vaccination in humans

F Hellgren, A Rosdahl, RA Cerveira, K Lenart… - JCI …, 2024‏ - pmc.ncbi.nlm.nih.gov
mRNA vaccines are likely to become widely used for the prevention of infectious diseases in
the future. Nevertheless, a notable gap exists in mechanistic data, particularly concerning …

[PDF][PDF] Increased age-adjusted cancer mortality after the third mRNA-lipid nanoparticle vaccine dose during the COVID-19 pandemic in Japan

M Gibo, S Kojima, A Fujisawa, T Kikuchi, M Fukushima… - Cureus, 2024‏ - cureus.com
During the COVID-19 pandemic, excess deaths including cancer have become a concern in
Japan, which has a rapidly aging population. Thus, this study aimed to evaluate how age …

Innate and Adaptive Immune Parameters following mRNA Vaccination in Mice

SR Bonam, NC Hazell, MJ Mathew, Y Liang, X Zhang… - Vaccines, 2024‏ - mdpi.com
The COVID-19 pandemic has raised the standard regarding the current vaccine
development pace, as several messenger RNA (mRNA)-lipid nanoparticle (LNP) vaccines …

Existing and emerging mRNA vaccines and their environmental impact: a transdisciplinary assessment

S Mueller - Environmental Sciences Europe, 2024‏ - Springer
Abstract mRNA vaccines have played a massive role during the COVID-19 pandemic and
are now being developed for numerous other human and animal applications. Nevertheless …

BNT162b2 COVID-19 vaccination in children alters cytokine responses to heterologous pathogens and Toll-like receptor agonists

A Noé, TD Dang, C Axelrad, E Burrell… - Frontiers in …, 2023‏ - frontiersin.org
Background Vaccines can have beneficial off-target (heterologous) effects that alter immune
responses to, and protect against, unrelated infections. The heterologous effects of COVID …

[PDF][PDF] SARS-CoV-2 vaccination and the multi-hit hypothesis of oncogenesis

RV Angues, YP Bustos - Cureus, 2023‏ - cureus.com
Cancer is a complex and dynamic disease. The “hallmarks of cancer” were proposed by
Hanahan and Weinberg (2000) as a group of biological competencies that human cells …

Impact of COVID-19, lockdowns and vaccination on immune responses in a HIV cohort in the Netherlands

T Otten, X Jiang, MK Gupta, N Vadaq… - Frontiers in …, 2024‏ - frontiersin.org
Introduction During the COVID-19 pandemic, major events with immune-modulating effects
at population-level included COVID-19 infection, lockdowns, and mass vaccinations …

[HTML][HTML] Long-Lasting Enhanced Cytokine Responses Following SARS-CoV-2 BNT162b2 mRNA Vaccination

G Cabău, M Badii, AM Mirea, OI Gaal, L van Emst… - Vaccines, 2024‏ - mdpi.com
The mRNA vaccine against COVID-19 protects against severe disease by the induction of
robust humoral and cellular responses. Recent studies have shown the capacity of some …